Advertisement
U.S. markets open in 8 hours 56 minutes
Advertisement

Kao Corporation (KAO.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
35.00+0.60 (+1.74%)
At close: 08:03AM CET

  • Dividend

    KAO.F announced a cash dividend of 75.00 with an ex-date of Dec. 28, 2023

Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close34.40
Open35.00
Bid35.05 x 20000
Ask36.15 x 20000
Day's Range35.00 - 35.00
52 Week Range32.30 - 38.51
Volume30
Avg. Volume3
Market Cap16.503B
Beta (5Y Monthly)0.10
PE Ratio (TTM)44.30
EPS (TTM)0.79
Earnings DateN/A
Forward Dividend & Yield1.06 (3.09%)
Ex-Dividend DateDec 28, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for KAO.F

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!

      TOKYO, November 27, 2023--Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a collaboration between Kirin iMUSE, Japan’s first*1 immune care brand, and Kao Healthya, Japan’s first*1 body fat care beverage brand from Kao Corporation (TOKYO:4452), and will be sold at drugstores nationwide and through Kirin Kyowa Hakko Bio mail order.

    • Business Wire

      Japan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao

      TOKYO, November 24, 2023--Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led by Wakayama Medical University and organized by the Health Promotion Research Center (HPRC), a non-profit organization. Kao and Kirin Holdings conducted a joint study from November 2022 to investigate the relationship between visceral fat and the plasmacytoid dendritic cells (pDC*3) activity*4, which are the command

    • Business Wire

      Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan

      TOKYO, May 26, 2023--Kao Corporation (TOKYO:4452), a Japan-based Group whose brand portfolio includes Attack, Bioré, Goldwell, Jergens, John Frieda, Kanebo, Laurier, Merries, and Molton Brown, released progress reports on its ESG (Environmental, Social, and Governance) strategy—the Kirei Lifestyle Plan. Details of its progress is released in the Kao Sustainability Report 2023. In addition to the results of its activities in 2022, Kao also released information on the results of its activities for